Recurrent tumor

Known as: Neoplasm Recurrence, Recurrent Neoplasm, tumor recurrence 
The reemergence of a neoplasm after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
The long noncoding RNA HOTAIR has been reported as a poor prognostic biomarker in patients with breast cancer. The aim of the… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Yes-associated protein (YAP), a downstream target of the Hippo signaling pathway, was recently linked to… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
UNLABELLED We evaluated the diagnostic accuracy of PET with l-methyl-(11)C-methionine ((11)C-MET) for the differentiation of… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE The purpose of this study was to evaluate prognostic factors in patients with recurrence after curative resection of… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who are at high risk for… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND AND PURPOSE Differentiation of tumor recurrence from treatment-related changes may be difficult with conventional MR… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
UNLABELLED Our purpose was to evaluate the ability of FDG PET to differentiate recurrent tumor from posttherapy radiation… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1996
Highly Cited
1996
PURPOSE Up to 30% to 40% of metastases from hormone receptor-positive primary breast cancer do not respond to endocrine therapy… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Axillary lymph node status has been the most important prognostic factor in operable breast carcinoma, but it does not… (More)
Is this relevant?